For Dyslipidemia

GLP-1 weight loss for high cholesterol.

Physician-reviewed care for adults with dyslipidemia and a BMI of 27 or higher

High cholesterol and excess weight often travel together. Sustained weight loss is one of the most reliable ways to improve triglycerides, raise HDL, and reduce overall cardiovascular risk. GLP-1 medications have shown lipid improvements in clinical trials of brand-name FDA-approved products. A licensed Puri-affiliated physician can evaluate whether compounded semaglutide or tirzepatide may fit your care plan.

High cholesterol and GLP-1: the practical overview.

Quick summary

High cholesterol and GLP-1: the practical overview.

If you have dyslipidemia and a BMI of 27 or higher, you meet a common clinical threshold for GLP-1 weight management therapy. Brand-name GLP-1 trials have shown improvements in triglycerides and HDL alongside weight loss; LDL changes are smaller and less reliable. GLP-1 is complementary to statin therapy, not a substitute for it.

Compounded semaglutide starts at $179/mo and compounded tirzepatide starts at $249/mo through Puri. Compounded versions have not been evaluated in lipid outcome trials. A licensed provider makes the prescribing decision based on your clinical picture. A prescription is not guaranteed.

BMI 27+
Plus comorbidity
Common eligibility threshold
Triglyc
Biggest improvement
From weight loss
Stack
With statin if needed
Complementary, not replacement

The Complete Guide

High cholesterol and GLP-1 weight loss: what to know

A practical guide for adults with elevated cholesterol or triglycerides who want to understand whether GLP-1 medications can help — and how they fit alongside existing lipid-lowering therapy.

Reviewed by Puri's care team12 minute read

What your lipid panel actually says

A standard lipid panel reports four numbers: total cholesterol, LDL (the kind that builds plaque), HDL (the kind that helps clear it), and triglycerides (circulating fats from food and metabolism). These four numbers, taken together, are one of the strongest predictors of cardiovascular risk we have. The thresholds that matter clinically are well established: LDL under 100 mg/dL is desirable, HDL above 40 in men and 50 in women is protective, and triglycerides under 150 are normal.

When the numbers drift in the wrong direction — high LDL, high triglycerides, or low HDL — the diagnosis is dyslipidemia, and the recommended interventions usually start with diet, exercise, and weight loss. If those are not enough, medication enters the conversation. The most common is a statin, which lowers LDL effectively. But statins do not address weight, and they only modestly improve HDL or triglycerides.

How weight loss changes the lipid panel

Sustained weight loss has measurable effects across the lipid panel, but not equally on all four numbers. The biggest changes are usually in triglycerides and HDL — both of which improve substantially with even modest weight reduction. LDL changes are smaller and less reliable, especially in the short term, because LDL is heavily genetically determined.

Clinical trial data on brand-name semaglutide and tirzepatide shows consistent improvements in triglycerides and HDL alongside the weight loss. The STEP and SURMOUNT trial programs both reported these effects. LDL changes were smaller, which is why GLP-1 medications are not a substitute for a statin if you have elevated LDL — they are complementary tools. Related: metabolic syndrome guide and fatty liver guide.

If your LDL is high and your triglycerides are high and your HDL is low and you are carrying extra weight, you are looking at a stack of related metabolic problems that often respond better to weight loss than to any single medication. GLP-1 is one tool. Statins are another. Lifestyle is the foundation under both.

Dyslipidemia as a qualifying comorbidity

FDA prescribing guidelines for brand-name semaglutide and tirzepatide for chronic weight management list two BMI thresholds: 30 or greater (obesity), or 27 or greater with at least one weight-related comorbidity. Dyslipidemia is one of those qualifying comorbidities. If your BMI is between 27 and 30 and you have a documented diagnosis of high cholesterol or high triglycerides, you likely meet clinical eligibility on paper.

Eligibility on paper is not the same as approval in practice. A licensed physician evaluates your full clinical picture — other conditions, medications, contraindications, and goals — before issuing a prescription. The final decision belongs to the doctor, not the website.

Can I take GLP-1 with my statin?

Yes, in most cases. There is no class-wide interaction between GLP-1 receptor agonists and statins. Many patients in clinical trials of brand-name GLP-1 medications were already on statin therapy, and the combination has been safely used in millions of patients globally.

The practical guidance: tell every prescribing doctor about every medication you take. Your Puri provider will document your statin and any other lipid-lowering drugs (ezetimibe, fibrates, PCSK9 inhibitors). Coordinate with your primary care physician or cardiologist on whether your dose may eventually change as your numbers improve. Do not stop a statin on your own, even if your LDL drops — the cardiovascular protection from statins is not just about the LDL number.

What else helps cholesterol

  • Mediterranean-style eating. Olive oil, fatty fish, vegetables, nuts, and whole grains have decades of evidence for improving lipid profiles and reducing cardiovascular events. The PREDIMED trial is the landmark study.
  • Soluble fiber. Oats, beans, lentils, apples, and psyllium husk all bind bile acids in the gut and modestly reduce LDL. Cheap, safe, additive to whatever else you're doing.
  • Aerobic exercise. 150 minutes per week of moderate-intensity cardio raises HDL and lowers triglycerides. Walking counts.
  • Reduce saturated fat and eliminate trans fats. Trans fats are the worst offender. Saturated fat is more nuanced than the headlines but moderation matters for most people with elevated LDL.
  • Limit alcohol. Alcohol is calorically dense and significantly raises triglycerides in many people.

How to get started

If you have a recent lipid panel, bring those numbers to your intake. If you do not, ask your primary care physician for one. The conversation with a Puri provider is much more useful when you can show your actual lab values rather than guessing.

Ready? Complete your assessment. A licensed Puri-affiliated physician will review your medical history and decide whether GLP-1 is the right next step. A prescription is not guaranteed.

Cited sources

Where the evidence comes from.

The research referenced throughout this guide draws from peer-reviewed clinical studies and guidelines published by medical professional societies. The studies describe findings for specific brand-name GLP-1 products. They do not represent promises of individual outcomes, and they do not apply directly to compounded medications.

Where the evidence comes from.

The American Heart Association and American College of Cardiology jointly publish blood cholesterol management guidelines covering statins, lifestyle, and weight loss as first-line interventions.

ACC/AHA Cholesterol Guidelines

The PREDIMED trial reported significant cardiovascular event reduction with a Mediterranean diet supplemented with olive oil or nuts.

PubMed: PREDIMED trial Mediterranean diet

The STEP and SURMOUNT clinical trial programs studied semaglutide and tirzepatide in adults with obesity and reported lipid panel improvements as secondary outcomes.

PubMed: GLP-1 lipid panel trials

The National Lipid Association publishes clinical recommendations on managing dyslipidemia, including the role of weight loss alongside pharmacotherapy.

National Lipid Association

The US Food and Drug Administration publishes prescribing information for FDA-approved GLP-1 products including indicated uses, dosing, and safety data.

FDA Drug Information

These links are provided for educational reference. Puri is not affiliated with these organizations. GLP-1 medications referenced may not be FDA-approved for the specific condition discussed. Compounded versions are not FDA-approved for any indication. Always talk to your healthcare provider before starting any new medication.

Programs

GLP-1 options available through Puri

Every plan includes a physician review, personalized dosing, provider messaging, and free shipping. A prescription is not guaranteed and requires licensed provider approval.

Most Popular

Compounded Semaglutide

$179/mo
  • Weekly self-injection
  • Compounded (not FDA-approved)
  • Personalized dosing
  • Provider oversight included
  • Free expedited shipping
Get Started

Compounded Tirzepatide

$249/mo
  • Weekly self-injection
  • Dual GLP-1 and GIP activity
  • Compounded (not FDA-approved)
  • Provider oversight included
  • Free expedited shipping
Get Started

Oral GLP-1 Tablets

$249/mo
  • No injections needed
  • Daily oral tablet
  • Compounded (not FDA-approved)
  • Provider oversight included
  • Free shipping
Get Started

Process

How it works

Three simple steps to start your journey

Get Approved
1

Get Approved

Complete a quick online evaluation to determine if treatment is right for you. No payment required upfront.

Get Prescribed
2

Get Prescribed

Once approved, a licensed provider will create a personalized treatment plan tailored to your needs and goals.

Receive Your Rx
3

Receive Your Rx

Your medication will be shipped directly to your door with free expedited delivery in discreet packaging.

FAQ

Common questions about high cholesterol and GLP-1

Educational answers, not medical advice.

Satisfaction Guarantee

Care that puts you first.

Personalized support from licensed providers, with a satisfaction guarantee on your first month (terms apply). Individual results vary. Outcomes are not guaranteed.